Hilaritas Press Podcasts Episode 54 – Iboga Psychedelic Therapy – Mike Gathers
14 snips
Feb 23, 2026 A first-person account of undergoing iboga psychedelic therapy and why he pursued it. He links chronic Lyme, past trauma, and immune struggles to his treatment choice. The narrative contrasts traditional retreat ceremonies with clinical ibogaine care. He describes intense visionary nights, bodily risks, and practical considerations like dosing, safety, and integration.
AI Snips
Chapters
Books
Transcript
Episode notes
Long Struggle With Lyme Led To Seeking Iboga
- Mike Gathers developed chronic Lyme after a staph infection and years of immune struggle that left him with low-grade infections and complex PTSD.
- He describes early psychedelic use, Grateful Dead experiences, and decades of therapy and experiential trainings before seeking iboga for persistent symptoms.
Iboga Acts As A Nervous System Tonic
- Iboga/ibogaine acts more like a nervous system tonic than classic psychedelics that target serotonin receptors.
- Mike contrasts it with mushrooms and LSD, saying iboga opens an unusually long epigenetic imprint window that can reset deep early-circuit imprints.
Do Medical Screening And Supervision For Iboga
- Avoid DIY use and get medical screening and supervision because high doses cause mobility problems and cardiac/liver risk.
- Clinics often require EKGs, monitor vitals, keep IV access, and won't accept incompatible long-acting opiates or many psych meds.
